Women's & Hormonal HealthThyroid & Autoimmune Health

Hypothyroidism and Hashimoto's Thyroiditis: TSH, Free T4, TPO Antibodies, and Levothyroxine

Hashimoto's thyroiditis is the most common cause of primary hypothyroidism in females and is due to an autoimmune destruction of thyroid follicular cells. This question will cover some laboratory findings to consider when diagnosing the condition, appropriate levothyroxine dosing, common factors which hinder absorption and diet.

Published: 2026-09-08Reviewed: October 2026Updated: 2026-11-03T09:20:54.099Z 10 min read 2280 Views
Listen to this guide Audio Edition

Hands-free audio narration

Educational Health Notice

This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.

Hypothyroidism and Hashimoto's Thyroiditis: TSH, Free T4, TPO Antibodies, and Levothyroxine

Quick Summary & Key Findings

Hypothyroidism results from insufficiency of thyroid hormones within the thyroid gland causing symptoms such as tiredness, unintentional weight gain, feeling cold, constipation and brain fog. In females over 90% of cases are due to Hashimoto’s thyroiditis which can be confirmed with a raised TSH (>4.5mIU/L), reduced free T4 and raised Thyroid Peroxidase (TPO) antibodies. Treatments involve taking Levothyroxine orally each day with water on an empty stomach half an hour to one hour before breakfast.

The thyroid is a butterfly shaped endocrine gland located at the front of the neck. Its main functions are regulation of your base metabolic rate, heart rate, body temperature and production of proteins within cells throughout the body. If the thyroid isn’t producing enough hormones it will cause everything to slow down.

Most cases of hypothyroidism in women (who are 5-8 times more likely to be diagnosed) are caused by Hashimoto’s Thyroiditis (chronic lymphocytic thyroiditis). This is an autoimmune disease whereby the body produces T-lymphocytes and autoantibodies that attack the Thyroid Peroxidase (TPO) and Thyroglobulin. This causes the follicles within the thyroid to shrink over time, meaning less hormones are produced.

As the initial symptoms of hypothyroidism can include mild tiredness, dry skin and mood swings they can often be put down to stress and ageing. However, knowing all the blood tests that show thyroid function and hormone replacement therapy is essential to getting your energy back.

Interpreting Thyroid Lab Panels: Beyond Standard TSH

A comprehensive endocrine evaluation examines the complete pituitary-thyroid feedback loop rather than relying on an isolated TSH test:
Thyroid Stimulating Hormone (TSH) is a hormone secreted by the anterior pituitary to stimulate production of thyroid hormones. Normal levels in clinic are between 0.45-4.5mIU/l. TSH can increase in primary hypothyroidism as a compensatory mechanism.
Free Thyroxine (Free T4) - Measures the amount of free T4 in the blood (normal=0.8-1.8ng/dL). Low Free T4 and high TSH confirms clinical hypothyroidism.
Free Triiodothyronine (Free T3) – Bioactive intracellular hormone formed from T4 mainly in the liver, kidneys and peripheral tissues. Normal range = 2.3 – 4.2pg/mL
Thyroid peroxidase antibodies (TPOAb), elevated levels (>35IU/mL) confirm that Hashimoto’s is autoimmune in origin. This indicates lymphocytic infiltration of the thyroid gland.
Subclinical Hypothyroidism: Raised TSH (between 4.5-10.0miu/L), Free T4 is normal. Considered for treatment if patient has raised antibodies, significant symptoms or if planning a pregnancy.

Levothyroxine Administration and Absorption Rules

Levothyroxine (synthetic T4) has a narrow therapeutic index and is notoriously prone to malabsorption if not taken correctly:
Timing and Fasting: Take it first thing in the morning with a big glass of plain water. Take on an empty stomach at least half an hour before eating, having coffee, tea or any other medication.
Patients who find it difficult to take their medication on an empty stomach in the morning can be prescribed the drug at night. Clinical trials have shown that taking levothyroxine at night (three to four hours after the last meal) gives equivalent or better absorption.
The 4-hour rule: Levothyroxine should be taken at least four hours apart from calcium supplements, Iron/Ferrous sulphate, Antacids (aluminium/magnesium), and Multivitamins.
Coffee and Fiber Interactions Drinking a caffeinated beverage or eating high fibre cereals within one hour may decrease drug availability by up to 30%.

Nutritional Cofactors and Autoimmune Support

Specific micronutrients serve as critical biochemical cofactors for thyroid hormone synthesis and T4-to-T3 deiodinase conversion:
Selenium (100-200mcg/day): An essential constituent of selenoproteins including glutathione peroxidase and deiodinases which protect the thyroid from oxidative stress during iodination. Can help reduce levels of TPO antibodies.
Zinc and Iron: Severe iron deficiency (ferritin <30 ng/mL) impairs heme-dependent thyroid peroxidase enzyme activity.
Iodine. While your body does need iodine to make thyroid hormone (T3/T4), taking high dose supplements of it (kelp/sea moss) can cause inflammation in Hashimoto’s and lead to a condition called the Wolff-Chaikoff effect where all thyroid production comes to a sudden halt.

Thyroid Peroxidase Autoimmunity, Peripheral Deiodination & ATA Clinical Targets

Hashimoto's thyroiditis (chronic lymphocytic thyroiditis) is an organ specific autoimmune disease involving cell mediated toxicity. This involves lymphocytic infiltration of the thyroid gland including CD4 T helper cells and CD8 cytotoxic T cells. Autoantibodies are also present in circulation including anti-Thyroid Peroxidase (anti-TPO) and anti-Thyroglobulin (anti-Tg). Destruction of the follicles causes a reduction in thyroxine (T4) being secreted into the blood stream. This loss causes the negative feedback loop from the pituitary to be lost. Thyroid stimulating hormone (TSH) is then over-secreted to compensate. Approximately 80% of triiodothyronine (T3) is found in the circulation in its active form having been converted from T4 via 5' deiodinase in the liver, kidney and skeletal muscles.
American Thyroid Association (ATA) reference ranges: Patients on levothyroxine (not pregnant adults), should be targeted to a serum TSH of 0.5-2.5mIU/L. Geriatrics (>70 years) should be safely targeted to a higher range of 3.0-6.0mIU/L to reduce risk of atrial fibrillation and reduced bone mineral density due to subclinical thyrotoxicosis.
Subclinical Hypothyroidism Algorithm: All patients with a serum TSH of 10.0mIU/L or above should be treated due to an increased risk of cardiovascular mortality and heart failure. Patients with a TSH of between 4.5-9.9mIU/L who have a positive anti-TPO titre, symptoms of goitre, pregnant or dyslipidaemia should also be treated.
Pharmacokinetics and dosing Levothyroxine The full replacement dose is around 1.6mcg/kg ideal body weight daily. This is reduced in those with coronary artery disease by starting at a lower dose (25-50mcg).
GI Malabsorption Levothyroxine is absorbed in the jejunum and ileum. Concomitant administration of calcium carbonate, ferrous sulfate, cholestyramine or proton pump inhibitors which lower gastric acidity required for tablet dissolution can reduce drug bioavailability by up to 50% so must be taken 4 hours apart.

Combination T4/T3 Evidence, Selenium Trials & Myxedema Coma Prevention

Levothyroxine is the global gold standard for treatment for hypothyroidism. However, some patients are persistently symptomatic with fatigue and cognitive symptoms despite biochemical normality. These patients may be affected by the deiodinase type 2 polymorphism (DIO2 Thr92Ala) which reduces conversion of T4 to T3 within cells. Desiccated thyroid extract or T3 (liothyronine) are commonly used in combination with levothyroxine but require careful monitoring due to quick gastrointestinal absorption, short serum half-life (18-24h) and potential increase in heart rate and arterial pulse pressure at rest.
Liothyronine (T3) Combination Trials Randomized trials suggest that physiological T4:T3 combinations (either 14:1 or 10:1) may be of benefit in some patients carrying DIO2 polymorphisms. However it should be taken twice daily to avoid supraphysiological adrenergic peaks after dosing.
Clinical evidence to support selenium supplementation. The CATALYST and associated auto-immune thyroid trials have shown that taking 200 mcg of selenomethionine per day will reduce anti-TPO antibodies by between 20-40% after 6-12 months. However, it is not reliable in restoring endogenous thyroid hormone synthesis.
This is an emergency situation where severe hypothyroidism occurs secondary to infection and/or surgery. There will be a low body temperature, slow heart rate, shallow breathing and brain dysfunction. The patient needs admitting to ICU for IV Levothyroxine (200-400mcg loading dose) and IV hydrocortisone (stress dose) to avoid adrenal crisis.
Pregnancy dose escalation: During early pregnancy there is an increased maternal requirement for thyroid hormone. This is due to increased TBG (thyroxine binding globulin) caused by increased oestrogen and stimulation of the thyroid gland by hCG produced by the placenta. Patients should empirically increase their Levothyroxine by 2 additional tablets per week on a positive pregnancy test.

Thyroid Sonographic Architecture, Doppler Vascularity & Micronutrient Co-Factors

High resolution ultrasound can provide key information about the morphology of the thyroid gland. In patients with chronic Hashimoto's thyroiditis, the fine homogeneous intermediate grey echotexture of the normal thyroid becomes coarse, heterogeneous and hypoechoic with fibrous echogenic septae causing a micro-nodular/pseudo-nodular appearance. Color Doppler interrogation often reveals normal or decreased vascularisation in late atrophic cases. This is in contrast to the intense diffusely hyper-vascular appearance (thyroid inferno) of Grave's thyrotoxicosis.
Thyroid Imaging Reporting and Data System (TIRADS): The ACR TI-RADS system assigns scores based on nodule composition, echogenicity, shape, margins and echogenic foci to establish thresholds for FNA biopsy of focal dominant nodules occurring in heterogeneous Hashimoto's thyroiditis.Thyroid Imaging Reporting and Data System (TIRADS): The ACR TI-RADS system assigns scores based on nodule composition, echogenicity, shape, margins and echogenic foci to establish thresholds for FNA biopsy of focal dominant nodules occurring in heterogeneous Hashimoto's thyroiditis.
Iodine Paradox (Wolff-Chaikoff Effect): Patients with underlying autoimmune thyroiditis can be overwhelmed by large amounts of exogenous iodine (kelp / seaweed tablets). This leads to long term inhibition of thyroid auto-regulation (Wolff Chaikoff effect), therefore preventing organification and causing severe manifest hypothyroidism.
Zinc/Copper Micronutrient Interactions: Zinc is an essential cofactor of thyroid hormone binding proteins and nuclear receptors. Zinc deficiency causes a decrease in 5'-deiodinase activity and hence reduces serum free T3 levels. Free T4 levels may be normal.
APS Screening. Due to the high frequency of coexisting organ specific autoimmunity in Hashimoto's thyroiditis, investigations for other autoimmune conditions should be actively pursued. This includes tTG-IgA testing for Celiac disease, Type 1 Diabetes, Vitiligo and Addisons disease (Morning Cortisol/ACTH).

Diagnostic Comparison: Complete Thyroid Function & Autoantibody Panel

Biomarker / AssayStandard Adult Reference RangePhysiological FunctionPattern in Hashimoto's HypothyroidismClinical Interpretation & Traps
Thyroid-Stimulating Hormone (TSH)0.45 – 4.50 mIU/L (Optimal: 0.5 – 2.5)Anterior pituitary hormone that stimulates thyroid follicular hormone synthesis and releaseElevated (>4.5 mIU/L, often >10 mIU/L in overt disease)Most sensitive screening biomarker; target range 0.5–2.5 on levothyroxine; high biotin intake (>5mg/day) can falsely lower TSH assay.
Free Thyroxine (Free T4)0.82 – 1.77 ng/dL (10.5 – 22.8 pmol/L)Unbound, biologically active prohormone available for peripheral tissue cellular deiodinationLow in overt hypothyroidism (<0.8 ng/dL); normal in subclinical hypothyroidismMeasure Free T4 directly via equilibrium dialysis; total T4 is distorted by pregnancy and estrogens which elevate thyroxine-binding globulin.
Free Triiodothyronine (Free T3)2.0 – 4.4 pg/mL (3.1 – 6.8 pmol/L)Active metabolic hormone with 4-fold higher affinity for nuclear thyroid receptors than T4Often normal until end-stage disease due to compensatory TSH-driven hyper-deiodinationPoor screening test for primary hypothyroidism; measuring free T3 alone will miss early overt hypothyroidism.
Thyroid Peroxidase Antibodies (Anti-TPO)<9.0 IU/mL (Negative)Autoantibodies directed against thyroid peroxidase, the enzyme essential for iodine organificationMarkedly elevated (>100 to >1,000 IU/mL in >95% of cases)Confirms autoimmune etiology; titers predict risk of progression from subclinical to overt hypothyroidism (4.3% per year vs 2.6%).
Thyroglobulin Antibodies (Anti-Tg)<1.0 IU/mL (Negative)Autoantibodies directed against thyroglobulin, the matrix protein for thyroid hormone synthesisElevated in 60–80% of Hashimoto's patientsComplementary autoimmune marker; vital to confirm negative status prior to using serum thyroglobulin for thyroid cancer surveillance.

Frequently Asked Questions

S
Clinical Reviewer License Verified

Dr. Shikha Sharma, MBBS

Founder & Medical Director, NutriHealth Delhi NCR; Clinical Nutrition Lead • MBBS (Maulana Azad Medical College)
Medical Review Board

Dr. Shikha Sharma is an MBBS graduate from Maulana Azad Medical College (MAMC), New Delhi, and a pioneer in clinical nutrition, gut health, and preventive lifestyle medicine in Delhi NCR with over 25 years of medical consulting experience.

License ID: DMC-12490
Medical Director, NutriHealth Delhi NCR; Consulting Preventive Physician
Medically evaluated on October 2026View Dr. Profile, Verified Credentials & Articles

References & Clinical Resources

  1. Clinical Research Faculty & Editorial Team. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2020-2026). [Access Resource Link] — Thyroid / American Thyroid Association
  2. Clinical Research Faculty & Editorial Team. Hashimoto Thyroiditis: Clinical Review and Management (2020-2026). [Access Resource Link] — The Lancet Diabetes & Endocrinology
  3. Clinical Research Faculty & Editorial Team. Clinical Practice Guidelines for the Care of Patients with Primary Hypothyroidism (2020-2026). [Access Resource Link] — Endocrine Practice
Article Tools & Sharing:
Educational Resources
Patient Community Doctor Reviewed

Reader Reviews & Clinical Q&A

Real experiences, reader questions, and verified physician guidance.

5.0 out of 5 (2 reviews)
CM
Claire M., PatientVerified Patient
•August 18, 2026

Finally a medical article that validates symptoms without dismissing them. The diagnostic checklist and hormone test breakdown gave me the confidence to request a full panel from my OB/GYN.

Dr. Alka Kriplani, MBBS, MD, FRCOG, FAMSSenior Obstetrician & Gynecologist
August 19, 2026

Patient self-advocacy backed by objective medical data is essential in women's healthcare, Claire. We hope your follow-up appointment provides clear clinical answers.

HS
Hannah S., Women's Health Physical TherapistHealthcare Professional
•August 29, 2026

The distinction between muscular hypertonicity and weakness in this guide is spot on. Too many online articles just prescribe generic exercises without explaining individual pelvic mechanics.

Dr. Alka Kriplani, MBBS, MD, FRCOG, FAMSSenior Obstetrician & Gynecologist
August 30, 2026

Accurate anatomical nuance prevents patients from inadvertently worsening their symptoms, Hannah. Thank you for your specialized insight!

Leave a Review or Ask a Medical Question

5 / 5 Stars
* Reviews are reviewed by our clinical editorial team in accordance with our medical policies.